Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): A randomized, placebo-controlled, phase 2 trial
de Zeeuw D et al. Lancet Diabetes Endocrinol 2018. doi: 10.1016/S2213-8587(18)30289-4
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.